BDBM300165 (3R)-1-[3-[(2-Chlorophenyl)methyl]-5-morpholin-4-yltriazolo[4,5-d]pyrimidin-7-yl]-3-methylpyrrolidin-3-ol::US9593123, Example 36

SMILES C[C@@]1(O)CCN(C1)c1nc(nc2n(Cc3ccccc3Cl)nnc12)N1CCOCC1

InChI Key InChIKey=SLGHMGZQUMCXDR-HXUWFJFHSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 300165   

TargetCannabinoid receptor 1(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM300165((3R)-1-[3-[(2-Chlorophenyl)methyl]-5-morpholin-4-y...)
Affinity DataEC50: >1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM300165((3R)-1-[3-[(2-Chlorophenyl)methyl]-5-morpholin-4-y...)
Affinity DataEC50:  220nMAssay Description:CHO cells expressing human CB1 or CB2 receptors are seeded 17-24 hours prior to the experiment 50.000 cells per well in a black 96 well plate with fl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent